ArticleTrials2019

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Grazia Daniela Femminella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.